Investigational drug · Phase 2
TRYP-0082
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Irritable Bowel Syndrome.
Phase 2Last checked: Nov 19, 2026Latest source record: Feb 5, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "TRYP-0082"
First trial start
2024
Jan 17, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "TRYP-0082", any sponsor or status.
Conditions studied
As listed on its trial records.
- Irritable Bowel Syndrome
Approved drugs for the same conditions: Irritable bowel syndrome · Rare and genetic disease · Gastroenterology and liver
Largest trials
Live from ClinicalTrials.gov: studies naming "TRYP-0082" as an intervention, largest first.
- Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)Active, not recruiting
TRYP TherapeuticsIndustry
NCT06206265 · 14 participants · Start Jan 17, 2024 · Primary completion Mar 1, 2026
Drug: TRYP-0082 · For: Irritable Bowel Syndrome
Sites: Boston, Massachusetts
TRYP TherapeuticsIndustry
NCT05035927 · 5 participants · Start Mar 16, 2022 · Primary completion Mar 7, 2024
Drug: TRYP-0082 · For: Binge Eating Disorder
Sites: Gainesville, Florida
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Irritable Bowel Syndrome
- BrenipatideLY3537031Phase 313 trials
Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major
- CamlipixantBLU-5937Phase 34 trials
GSK · Refractory Chronic Cough, Cough, Irritable Bowel Syndrome
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.